| Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors MJ Peart, GK Smyth, RK Van Laar, DD Bowtell, VM Richon, PA Marks, ... Proceedings of the National Academy of Sciences 102 (10), 3697-3702, 2005 | 625 | 2005 |
| Options available—from start to finish—for obtaining data from DNA microarrays II AJ Holloway, RK Van Laar, RW Tothill, DDL Bowtell nature genetics 32 (4), 481-489, 2002 | 381 | 2002 |
| Empirical array quality weights in the analysis of microarray data ME Ritchie, D Diyagama, J Neilson, R van Laar, A Dobrovic, A Holloway, ... BMC bioinformatics 7 (1), 1-16, 2006 | 298 | 2006 |
| Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. AM Glas, L Knoops, L Delahaye, MJ Kersten, RE Kibbelaar, LA Wessels, ... | 266 | 2007 |
| Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix BL Eckhardt, BS Parker, RK Van Laar, CM Restall, AL Natoli, MD Tavaria, ... Molecular Cancer Research 3 (1), 1-13, 2005 | 265 | 2005 |
| An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK Van Laar, ... Cancer Research 65 (10), 4031-4040, 2005 | 241 | 2005 |
| Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary HM Horlings, RK van Laar, JM Kerst, HH Helgason, J Wesseling, ... Journal of Clinical Oncology 26 (27), 4435-4441, 2008 | 190 | 2008 |
| Effect of ASCO/CAP guidelines for determining ER status on molecular subtype B Deyarmin, JL Kane, AL Valente, R van Laar, C Gallagher, CD Shriver, ... Annals of surgical oncology 20 (1), 87-93, 2013 | 128 | 2013 |
| Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary J Bridgewater, R Van Laar, A Floore, L Van'T Veer British journal of cancer 98 (8), 1425-1430, 2008 | 108 | 2008 |
| Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen M Kok, SC Linn, RK Van Laar, MPHM Jansen, TM Van den Berg, ... Breast cancer research and treatment 113 (2), 275-283, 2009 | 83 | 2009 |
| Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary RK van Laar, XJ Ma, D de Jong, D Wehkamp, AN Floore, MO Warmoes, ... International journal of cancer 125 (6), 1390-1397, 2009 | 52 | 2009 |
| Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use R Van Laar, R Flinchum, N Brown, J Ramsey, S Riccitelli, C Heuck, ... BMC medical genomics 7 (1), 1-13, 2014 | 45 | 2014 |
| Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer RK Van Laar BMC Medical Genomics 5 (1), 1-12, 2012 | 41 | 2012 |
| Development and validation of a plasma-based melanoma biomarker suitable for clinical use R Van Laar, M Lincoln, B Van Laar British journal of cancer 118 (6), 857-866, 2018 | 38 | 2018 |
| Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus JR White, V Boyd, GS Crameri, CJ Duch, RK van Laar, LF Wang, ... Journal of general virology 86 (10), 2839-2848, 2005 | 38 | 2005 |
| System and method for classification of patients R Van Laar US Patent 8,999,648, 2015 | 36 | 2015 |
| System and method for classification of patients R Van Laar US Patent 8,999,648, 2015 | 36 | 2015 |
| System and method for classification of patients R Van Laar US Patent 8,999,648, 2015 | 36 | 2015 |
| Recreational music-making alters gene expression pathways in patients with coronary heart disease B Bittman, DT Croft Jr, J Brinker, R van Laar, MN Vernalis, DL Ellsworth Medical science monitor: international medical journal of experimental and …, 2013 | 31 | 2013 |
| An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer RK Van Laar British journal of cancer 103 (12), 1852-1857, 2010 | 31 | 2010 |
Annuska M GlasAgendiaVerified email at agendia.com
